Vilma Yuzbasiyan‐Gurkan

Michigan State University — United States

Medicine · Health Sciences

37h-index4.3kcitations145works0.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Veterinary Oncology Research(46), Trace Elements in Health(33), Virus-based gene therapy research(31), Mast cells and histamine(17), Sarcoma Diagnosis and Treatment(16)

Publications145 total

Transcriptome Analysis of Canine Histiocytic Sarcoma Tumors and Cell Lines Reveals Multiple Targets for Therapy
Cancers·2025· 1 citedOpen Access
Gene expression profile comparison of primary and pulmonary metastatic lesions in a dog with appendicular osteosarcoma and hypertrophic osteopathy
Veterinary oncology.·2024Open Access
BRUSH Summer Research Program: Promoting Science Identity in Underrepresented Veterinary and Undergraduate Students
Journal of Veterinary Medical Education·2024· 1 citedOpen Access
Canine Histiocytic and Hemophagocytic Histiocytic Sarcomas Display KRAS and Extensive PTPN11/SHP2 Mutations and Respond In Vitro to MEK Inhibition by Cobimetinib
Genes·2024· 2 citedOpen Access
Gene expression profile comparison of primary and pulmonary metastatic lesions in a dog with appendicular osteosarcoma and hypertrophic osteopathy
Research Square (Research Square)·2024Open Access
Abstract 3187: Enhancing STING activation by cyclic dinucleotide-manganese particles for systemic cancer immunotherapy
Cancer Research·2024
Establishment and Characterization of Cell Lines from Canine Metastatic Osteosarcoma
Cells·2023· 3 citedOpen Access
Genome-wide methylation patterns from canine nanopore assemblies
G3 Genes Genomes Genetics·2023· 14 citedOpen Access
BET Inhibitor JQ1 Attenuates Feline Leukemia Virus DNA, Provirus, and Antigen Production in Domestic Cat Cell Lines
Viruses·2023· 2 citedOpen Access
Review for "Reconstruction surgery using polypropylene mesh after extensive resection of a costal osteosarcoma in a dog"
2023
Supplementary Figure S2 from Targeting MEK in a Translational Model of Histiocytic Sarcoma
2023Open Access
Supplementary Table S2 from Targeting MEK in a Translational Model of Histiocytic Sarcoma
2023Open Access
Supplementary Table S1 from Targeting MEK in a Translational Model of Histiocytic Sarcoma
2023Open Access
Supplementary Table S4 from Targeting MEK in a Translational Model of Histiocytic Sarcoma
2023Open Access
Supplementary Table S3 from Targeting MEK in a Translational Model of Histiocytic Sarcoma
2023Open Access
Supplementary Figure S1 from Targeting MEK in a Translational Model of Histiocytic Sarcoma
2023Open Access
Data from Targeting MEK in a Translational Model of Histiocytic Sarcoma
2023Open Access
Supplementary Figure S2 from Targeting MEK in a Translational Model of Histiocytic Sarcoma
2023Open Access
Supplementary Table S3 from Targeting MEK in a Translational Model of Histiocytic Sarcoma
2023Open Access
Supplementary Table S1 from Targeting MEK in a Translational Model of Histiocytic Sarcoma
2023Open Access
page 1 of 8Next →

Frequent Co-authors

George J. Brewer(21), Matti Kiupel(15), Patrick J. Venta(10), Joshua D. Webster(6), Robert D. Dick(4), V Johnson(4), Tuddow Thaiwong(4), John B. Kaneene(3), William D. Schall(3), Karoline V. Gleixner(3), Emir Hadzijusufovic(3), Michael Willmann(3), Peter Valent(3), Jayne T. Tung(3), Lee Alexander(3), John P. Caron(3), Manish Neupane(2), Jianping Li(2), Emmalena Gregory-Bryson(2), Elizabeth Bartlett(2)